Tinea capitis in an adult patient under treatment with trastuzumab.
Mansur
A Tülin
AT
Artunkal
Seza
S
Ener
Beyza
B
D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage* / Q000009:adverse effects*; D000935:Antifungal Agents / Q000008:administration & dosage; D000077768:Ciclopirox; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects*; D008853:Microscopy; D008864:Microsporum / Q000302:isolation & purification*; D008875:Middle Aged; D009172:Mycology / Q000379:methods; D009281:Naphthalenes / Q000008:administration & dosage; D011728:Pyridones / Q000008:administration & dosage; D000077291:Terbinafine; D014006:Tinea Capitis / Q000175:diagnosis* / Q000473:pathology; D000068878:Trastuzumab; D016896:Treatment Outcome
D061067:Antibodies, Monoclonal, Humanized; D000935:Antifungal Agents; D007155:Immunologic Factors; D009281:Naphthalenes; D011728:Pyridones; D000077768:Ciclopirox; D000077291:Terbinafine; D000068878:Trastuzumab